High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

被引:98
作者
Mohty, M
Faucher, C
Vey, N
Stoppa, AM
Viret, F
Chabbert, I
Chabannon, C
Bouabdallah, R
Ladaique, P
Collet, L
Zandotti, C
Maraninchi, D
Baise, D
机构
[1] Inst J Paoli I Calmettes, UTTC, Dept Hematol, F-13273 Marseille 9, France
[2] Inst J Paoli I Calmettes, Dept Med Oncol, F-13273 Marseille, France
[3] Inst J Paoli I Calmettes, Dept Microbiol, F-13273 Marseille 9, France
[4] Hop Enfants La Timone, Virol Lab, F-13385 Marseille, France
[5] Univ Mediterranee, Marseille, France
关键词
allogeneic bone marrow transplantation; non-myeloablative conditioning; cytomegalovirus; septicemia;
D O I
10.1038/sj.bmt.1702509
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
New approaches using nonmyeloablative-conditioning regimens have been developed to cause minimal procedure-related toxicity. Such novel therapeutic options are being explored with good preliminary results concerning feasibility and engraftment. However many aspects remain under-evaluated, and few data are available about viral and nonviral infections after these highly immunosuppressive regimens, We present our preliminary data on 21 patients receiving a highly immunosuppressive conditioning strategy, focusing on early infectious complications, Early viral infections before day 45, especially CMV, occurred at a high rate (65%). Furthermore, 33% of patients presented with late bacterial infections (predominately gram negative) although they were not neutropenic compared to conventional conditioning regimens. Although there is presently real interest in these new conditioning regimens which result in reduced immediate transplant-related mortality, it is important that investigators be aware of these pitfalls which may secondarily increase transplant toxicity, Further studies are needed to confirm these findings.
引用
收藏
页码:251 / 255
页数:5
相关论文
共 20 条
[1]  
BACIGALUPO A, 1995, BONE MARROW TRANSPL, V16, P155
[2]   Graft-versus-tumour and graft-versus-leukaemia effect in patient with concurrent breast cancer and acute myelocytic leukaemia [J].
BenYosef, R ;
Or, R ;
Nagler, A ;
Slavin, S .
LANCET, 1996, 348 (9036) :1242-1243
[3]   Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies:: a pilot study [J].
Blaise, D ;
Jourdan, E ;
Michallet, M ;
Jouet, JP ;
Boiron, JM ;
Michel, G ;
Faucher, C ;
Fégueux, N ;
Schuller, MP ;
Badri, N ;
Chabannon, C ;
Maraninchi, D .
BONE MARROW TRANSPLANTATION, 1998, 22 (12) :1153-1158
[4]   Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle [J].
Blaise, D ;
Kuentz, M ;
Fortanier, C ;
Bourhis, JH ;
Milpied, N ;
Sutton, L ;
Jouet, JP ;
Attal, M ;
Bordigoni, P ;
Cahn, JY ;
Boiron, JM ;
Schuller, MP ;
Moatti, JP ;
Michalle, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :537-546
[5]   BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES IN PATIENTS AGED 30 YEARS OR OLDER [J].
BLUME, KG ;
FORMAN, SJ ;
NADEMANEE, AP ;
ODONNELL, MR ;
SNYDER, DS ;
FAHEY, JL ;
SNIECINSKI, IJ ;
FINDLEY, DO ;
LIPSETT, JA ;
ZAIA, JA ;
METTER, GE ;
HILL, LR .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (10) :1489-1492
[6]  
BOECKH M, 1992, BLOOD, V80, P1358
[7]   INCREASING UTILIZATION OF ALLOGENEIC BONE-MARROW TRANSPLANTATION - RESULTS OF THE 1988-1990 SURVEY [J].
BORTIN, MM ;
HOROWITZ, MM ;
RIMM, AA .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (06) :505-512
[8]  
EINSELE H, 1993, BLOOD, V82, P1672
[9]   IDENTICAL-TWIN BONE-MARROW TRANSPLANTS FOR LEUKEMIA [J].
GALE, RP ;
HOROWITZ, MM ;
ASH, RC ;
CHAMPLIN, RE ;
GOLDMAN, JM ;
RIMM, AA ;
RINGDEN, O ;
STONE, JAV ;
BORTIN, MM .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (08) :646-652
[10]   Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy [J].
Giralt, S ;
Estey, E ;
Albitar, M ;
vanBesien, K ;
Rondon, G ;
Anderlini, P ;
OBrien, S ;
Khouri, I ;
Gajewski, J ;
Mehra, R ;
Claxton, D ;
Andersson, B ;
Beran, M ;
Przepiorka, D ;
Koller, C ;
Kornblau, S ;
Korbling, M ;
Keating, M ;
Kantarjian, H ;
Champlin, R .
BLOOD, 1997, 89 (12) :4531-4536